Overview


According to FutureWise analysis the market for Smart Inhalers in 2023 is US$ 0.22 billion, and is expected to reach US$ 1.32 billion by 2031 at a CAGR of 25.30%.

Smart inhalers are a type of inhaler device that is equipped with sensors and wireless technology, such as Bluetooth, enabling patients to track and manage their COPD or asthma more effectively. These devices work by monitoring the patient's inhaler usage, collecting data on the frequency and timing of inhalations, and transmitting this data to a smartphone app or other digital platform. Smart inhalers can help patients to manage their respiratory conditions more effectively by providing them with real-time feedback on their inhaler use and medication adherence. They can also help healthcare providers to monitor patient adherence to treatment plans, adjust medications as needed, and provide more personalized care.

Smart inhalers can be particularly useful for patients with severe or poorly controlled asthma or COPD and for individuals who are struggling to manage their symptoms with traditional inhalers. They are also helpful for patients who have difficulty remembering to take their medications as prescribed, as the device can provide reminders and alerts when doses are missed.

The smart inhalers market has been experiencing significant expansion in recent times and is expected to expand in the coming years. The market is being driven by various factors, including the increasing prevalence of respiratory diseases such as asthma and COPD, the need for more effective management of these conditions, and the growing acceptance of digital technologies in healthcare. One of the key drivers of the smart inhalers market is the increasing prevalence of respiratory diseases. According to the World Health Organization (WHO), 339 million people worldwide suffer from asthma and COPD. Therefore, there is a rising need for more effective management of these conditions, and smart inhalers have emerged as a promising solution. Smart inhalers offer a number of advantages over traditional inhalers. They are equipped with sensors and Bluetooth technology, which allow patients to monitor their inhaler usage and track their symptoms in real-time. Healthcare professionals can use this information to develop more individualised and successful treatment programs. The growing use of digital technologies in healthcare is another factor boosting the market for smart inhalers. The increasing accessibility of smartphones and other mobile devices has resulted in patients growing more accustomed to utilizing digital tools to manage their health. Smart inhalers are part of a larger trend toward digital health solutions, which offer patients greater convenience, control, and access to care.

Despite the promising outlook for the smart inhalers market, there are also several challenges that need to be addressed. The high cost of smart inhaler devices is a significant obstacle to their adoption, particularly for patients who cannot afford them. Furthermore, there are concerns about data privacy and security, and the implementation of stronger regulatory frameworks is crucial to ensure the efficacy and safety of these devices.

FutureWise Market Research has published a report that provides an insightful analysis of Smart Inhalers Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Smart Inhalers Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Adherium Ltd.
  • AstraZeneca PLC
  • Boehringer Ingelheim Group
  • Cohero Health Inc.
  • GlaxoSmithKline plc
  • Novartis International AG
  • OPKO Health Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Vectura Group plc
  • ResMed Inc. (Propeller Health)

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product

  • Inhalers
    • Dry Powder Inhalers
    • Metered Dose Inhalers
  • Nebulizers

By Indication

  • Asthma
  • COPD

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa   

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022. North America is currently dominating the smart inhalers market, accounting for the biggest share of the global market. The dominance of North America in the smart inhaler market can be attributed to several factors, including a well-established healthcare infrastructure and the region's high incidence rate of respiratory diseases, and the growing adoption of digital health technologies. The U.S. is the largest market for smart inhalers in North America, with a significant number of patients suffering from respiratory diseases such as asthma and COPD. Canada is another significant market for smart inhalers in North America, driven by the growing adoption of digital health solutions and the increasing prevalence of respiratory diseases. The Canadian government has also been actively promoting the adoption of digital health technologies, which is anticipated to drive further growth in the market.

  • Tier 1 players- established companies in the market with major market share
  • Tier 2 players
  • New Entrants
  • Emerging players which are growing rapidly

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data points affecting market growth

  • To provide with an exhaustive analysis on the Smart Inhalers Market By Product, By Indication, By Distribution Channel and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches.

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to:sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Smart Inhalers Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Smart Inhalers Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Smart Inhalers Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Smart Inhalers Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Inhalers
         1.1. Dry Powder Inhalers
         1.2. Metered Dose Inhalers
        2. Nebulizers

  • 8.   Smart Inhalers Market, By Indication Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Asthma
        2. COPD

  • 9.   Smart Inhalers Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies

  • 10.   North America Smart Inhalers Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Smart Inhalers Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Smart Inhalers Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Smart Inhalers Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Adherium Ltd.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. AstraZeneca PLC
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Boehringer Ingelheim Group.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Cohero Health Inc.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. GlaxoSmithKline plc
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Novartis International AG
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. OPKO Health Inc. ResMed Inc. (Propeller Health)
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Teva Pharmaceutical Industries Ltd.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Vectura Group plc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
            10. ResMed Inc. (Propeller Health)
          10.1. Company Overview
          10.2. Product Portfolio
          10.3. SWOT Analysis
          10.4. Financial Overview
          10.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients